The Patent Finder

Viacell, Inc.

Also on record
Records under this name other than the patents Viacell, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Viacell, Inc.

PatentTitleStatus Expires Confidence
US 8,759,315Methods for rejuvenating
Lapsed on the fee record
Ended Jun 24, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jun 24, 2026From the USPTO record
US 8,613,906Treatment of ischemia using stem cells
Formerly held
Lapsed on the fee record
Ended Dec 24, 2025 · From the USPTO record
Lapsed on the fee recordEnded Dec 24, 2025From the USPTO record
US 7,452,529Treatment of muscular dystrophy with cord blood cells
Formerly held
Term ended
Term ended Jul 23, 2022 · From the USPTO record
Term endedTerm ended Jul 23, 2022From the USPTO record
US 7,811,557Methods for improving central nervous system functioning
Formerly held
Term ended
Term ended May 11, 2022 · From the USPTO record
Term endedTerm ended May 11, 2022From the USPTO record
US 7,687,468Rejuvenation of stored blood
Lapsed on the fee record
Ended Mar 30, 2022 · From the USPTO record
Lapsed on the fee recordEnded Mar 30, 2022From the USPTO record
US 7,560,280Human cord blood derived unrestricted somatic stem cells (USSC)
Formerly held
Lapsed on the fee record
Ended Jul 14, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jul 14, 2021From the USPTO record
US 7,556,801Human cord blood derived unrestricted somatic stem cells (USSC)
Formerly held
Lapsed on the fee record
Ended Jul 7, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jul 7, 2021From the USPTO record
US 6,866,843Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
Term ended
Term ended May 23, 2021 · From the USPTO record
Term endedTerm ended May 23, 2021From the USPTO record
US 8,337,833Methods of improving central nervous system functioning
Term ended
Term ended Oct 27, 2020 · From the USPTO record
Term endedTerm ended Oct 27, 2020From the USPTO record
US 6,429,012Cell population containing non-fetal hemangioblasts and method for producing same
Formerly held
Term ended
Term ended Oct 6, 2017 · From the USPTO record
Term endedTerm ended Oct 6, 2017From the USPTO record
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited